Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention

Circulation Journal

Volumn 73, Issue 12, 2009, Pages 2229-2235

  Choi, Cheol Ung ^a   Rha, Seung Woon ^a   Chen, Kang Yin ^a   Li, Yong Jian ^a   Poddar, Kanhaiya L ^a   Jin, Zhe ^a   Minami, Yoshiyasu ^a   Suh, Soon Yong ^b   Na, Jin Oh ^a   Lim, Hong Euy ^a   Kim, Jin Won ^a   Kim, Eung Ju ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a  

^a Korea University College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Acute myocardial infarction; Paclitaxel eluting stents; Sirolimus eluting stents; Zotarolimus eluting stents

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; CYPHER; ENDEAVOR; HEPARIN; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADD ON THERAPY; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REPEAT PROCEDURE; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PACLITAXEL; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TREATMENT OUTCOME;

EID: 73349098402     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1086     Document Type: Article

References (27)

1. Kandzari DE, Roe MT, Ohman EM, Milford-Beland S, Chen AY, Lytle BL, et al. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2005; 96: 750-755.
2. Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
3. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005; 95: 640-643.
4. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, et al, TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
5. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006; 355: 1105-1113.
6. Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O'Neill WW, et al. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). Am J Cardiol 2009; 15: 181-186.
7. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007; 49: 1924-1930.
8. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drugeluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
9. Takahashi S, Kaneda H, Tanaka S, Miyashita Y, Shiono T, Taketani Y, et al. Late angiographic stent thrombosis after sirolimus-eluting stent implantation. Circ J 2007; 71: 226-228.
10. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-1039.
11. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, et al, Korea Acute Myocardial Infarction Registry Investigators. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008; 72: 392- 398.
12. Park KW, Cho YS, Chung JW, Yeon TJ, Chae IH, Choi DJ, et al. One year clinical and 6 month angiographic results of drug eluting stents for ST elevation acute myocardial infarction: 'Real world' comparison between sirolimus- and paclitaxel-eluting stents. Int J Cardiol 2008; 131: 350-355.
13. Mauri L, Hseih WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
14. Katritsis DG, Korovesis S, Karabinos I, Giazitzoglou E, Theodorou S, Karvouni E, et al. Sirolimus-versus paclitaxel-eluting stents: A comparison of two consecutive series in routine clinical practice. J Interv Cardiol 2006; 19: 3- 37.
15. Hofma SH, Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, et al. One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart 2005; 91: 1176-1180.
16. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Clark MR, Cohen BM, et al. Two-year outcomes after sirolimus-eluting stent implantation: Results from the SIRIUS trial. J Am Coll Cardiol 2006; 47: 1350-1355.
17. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schömig A, Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006; 27: 260-266.
18. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al, ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005; 293: 165-171.
19. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, et al, ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005; 353: 663-670.
20. Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005; 353: 653-662.
21. Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, et al. Comparison of 3-year clinical outcome of sirolimus-and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007; 99: 1027-1032.
22. Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, et al. Predictive factors of restenosis after coronary implantation of sirolimus-or paclitaxel-eluting stents. Circulation 2006; 113: 2293-2300.
23. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, et al, SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773- 3380.
24. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al, TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005; 294: 1215-1223.
25. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273-2278.
26. Ramcharitar S, Gaster AL, Daemen J, Serruys P. Drug-eluting stents, restenosis and revascularization. Herz 2007; 32: 287-295.
27. Hedström E, Aström-Olsson K, Ohlin H, Frogner F, Carlsson M, Billgren T, et al. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J 2007; 41: 44-50.